An observational study in Hypogonadotropic Hypogonadism, Reproductive Disorder and Kallmann Syndrome, sponsored by Stephanie B. Seminara, MD. Completed at 1 site in United States. Open to participants aged 1 Year and older. Per ClinicalTrials.gov, last updated 2026-07-13.
Sponsored by Stephanie B. Seminara, MD · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 16 studies in Kallmann Syndrome with a site in United States — 1 open to participants now, 2 under way, none of them phase 3. Kallmann Syndrome · United States.
Among the 16 studies in Kallmann Syndrome with a site in United States, this one is the only one that started in 2021, is one of 6 observational ones, and was the 16th registered.
23 studies on the registry are indexed under Kallmann Syndrome; 5 are open to participants now.
Browse Kallmann Syndrome studies →1 of the 16 studies in Kallmann Syndrome with a site in United States is open now. Recruiting first, the newest first:
National Institute of Environmental Health Sciences (NIEHS) · Sites in United States
Ages 6 wk–120 yrs
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 4 Kallmann Syndrome studies recruiting now, 2 set no upper age limit and 1 stops at 75 or younger; 2 take children under 18; 1 takes healthy volunteers.
This study: 1 Year and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
First in 1989; this study’s year is marked. 1 started in 2021.
By drug class, each counting the studies that test any of its medicines:
Median enrollment 108 across the 10 interventional studies, 539 across the 6 observational. Of the 12 that completed or were terminated, 1 (8%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 16 has an industry lead sponsor. The 6 most frequent:
Stephanie B. Seminara, MD is the lead sponsor of 12 studies on the registry; 3 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 3 (50%) have results posted.
Stephanie B. Seminara, MD has 1 study filed under Kallmann Syndrome — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 16 studies in Kallmann Syndrome with a site in United States, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The goal of this study is to learn more about the genes that control puberty and reproduction in humans.
All study subjects will undergo the same activities. Subjects will provide up to five tubes of blood for genetic analysis, complete a smell test, and answer questions about their health and family history.
23 studies on the registry are indexed under Kallmann Syndrome; 5 are open to participants now.
Browse Kallmann Syndrome studies →Stephanie B. Seminara, MD is the lead sponsor of 12 studies on the registry; 3 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 3 (50%) have results posted.
Compared within Kallmann Syndrome, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Hypogonadism. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Healthy controls and individuals with reproductive disorders and their affected and unaffected family members
Participants must be healthy controls or belong to one of the following categories:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Healthy controls or individuals with reproductive disorders and their affected and unaffected family members
Genetic variation
Identification of one or more genetic variations related to reproductive disorders
Time frame: Day 1
Plan to share: No
No publications or documents are linked to this record.
Ran from Jan 2021 to primary completion in Mar 2026, 62 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Stephanie B. Seminara, MD